Graham RP, Nair AA, Davila JI et al (2017) Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene. Mod Pathol 30:1443–1452

Article  PubMed  CAS  Google Scholar 

Spans L, Fletcher CD, Antonescu CR et al (2016) Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol 239:335–343

Article  PubMed  PubMed Central  CAS  Google Scholar 

WHO Classification of Tumours Editorial Board. Digestive system tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1). https://publications.iarc.fr/579.

WHO Classification of Tumours Editorial Board. Head and neck tumours. Lyon (France): International Agency for Research on Cancer; 2023. (WHO classification of tumours series, 5th ed.; vol. 9). https://publications.iarc.who.int/629.

Agaram NP, Zhang L, Sung YS et al (2019) GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Mod Pathol 32:1617–1626

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saoud C, Agaimy A, Dermawan JK et al. (2024) A comprehensive clinicopathologic and molecular reappraisal of GLI1-altered mesenchymal tumors with pooled outcome analysis showing poor survival in GLI1- amplified versus GLI1-rearranged tumors. Am J Surg Pathol 48:1302-1317

Kerr DA, Pinto A, Subhawong TK et al (2019) Pericytoma with t(7;12) and ACTB-GLI1 fusion: reevaluation of an unusual entity and its relationship to the spectrum of GLI1 fusion-related neoplasms. Am J Surg Pathol 43:1682–1692

Article  PubMed  PubMed Central  Google Scholar 

Pettus JR, Kerr DA, Stan RV et al (2021) Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1-FOXO4 fusion. Genes Chromosomes Cancer 60:116–122

Article  PubMed  CAS  Google Scholar 

Argani P, Boyraz B, Oliva E et al (2022) GLI1 gene alterations in neoplasms of the genitourinary and gynecologic tract. Am J Surg Pathol 46:677–687

Article  PubMed  PubMed Central  Google Scholar 

Machado I, Agaimy A, Giner F et al (2024) The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms. Virchows Arch 484:765–775

Article  PubMed  CAS  Google Scholar 

Warmke LM, Michal M, Martinek P et al (2023) “PRRX1-rearranged mesenchymal tumors”: expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature. Virchows Arch 483:207–214

Article  PubMed  CAS  Google Scholar 

Parrack PH, Marino-Enriquez A, Fletcher CDM, Hornick JL, Papke DJ Jr (2023) GLI1 immunohistochemistry distinguishes mesenchymal neoplasms with GLI1 alterations from morphologic mimics. Am J Surg Pathol 47:453–460

Article  PubMed  Google Scholar 

Xu B, Chang K, Folpe AL et al (2020) Head and neck mesenchymal neoplasms with GLI1 gene alterations: a pathologic entity with distinct histologic features and potential for distant metastasis. Am J Surg Pathol 44:729–737

Article  PubMed  PubMed Central  Google Scholar 

Antonescu CR, Agaram NP, Sung YS et al (2018) A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: expanding the spectrum of pathologic entities with ACTB/MALAT1/PTCH1-GLI1 fusions. Am J Surg Pathol 42:553–560

Article  PubMed  PubMed Central  Google Scholar 

Cloutier JM, Kerr DA (2024) GLI1-altered mesenchymal tumors. Surg Pathol Clin 17:13–24

Article  PubMed  Google Scholar 

Argani P, Dickson BC, Gross JM et al (2023) Ossifying fibromyxoid tumor of the genitourinary tract: report of 4 molecularly confirmed cases of a diagnostic pitfall. Am J Surg Pathol 47:709–716

Article  PubMed  PubMed Central  Google Scholar 

Al-Ahmadie HA, Yilmaz A, Olgac S, Reuter VE (2007) Glomus tumor of the kidney: a report of 3 cases involving renal parenchyma and review of the literature. Am J Surg Pathol 31:585–591

Article  PubMed  Google Scholar 

Argani P, Pawel B, Szabo S, Reyes-Múgica M, Timmons C, Antonescu CR (2018) Diffuse strong BCOR immunoreactivity is a sensitive and specific marker for clear cell sarcoma of the kidney (CCSK) in pediatric renal neoplasia. Am J Surg Pathol 42:1128–1131

Article  PubMed  PubMed Central  Google Scholar 

Argani P, Perlman EJ, Breslow NE, Browning NG, Green DM, D’Angio GJ, Beckwith JB (2000) Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 24:4–18

Article  PubMed  CAS  Google Scholar 

Calio A, Eble JN, Grignon DJ, Delahunt B (2016) Mixed epithelial and stromal tumor of the kidney: a clinicopathologic study of 53 cases. Am J Surg Pathol 40:1538–1549

Article  PubMed  Google Scholar 

Michal M, Hes O, Bisceglia M et al (2004) Mixed epithelial and stromal tumors of the kidney. A report of 22 cases. Virchows Arch 445:359–367

Article  PubMed  Google Scholar 

Saoud C, Agaimy A, Dermawan JK, Chen JF, Rosenblum MK, Dickson BC, Dashti N, Michal M, Kosemehmetoglu K, Din NU, Albritton K, Agaram NP, Antonescu CR (2024) A comprehensive clinicopathologic and molecular reappraisal of GLI1 -altered mesenchymal tumors with pooled outcome analysis showing poor survival in GLI1 - amplified versus GLI1- rearranged tumors. Am J Surg Pathol 2024(48):1302–1317

Article  Google Scholar